JP2015504438A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015504438A5 JP2015504438A5 JP2014542858A JP2014542858A JP2015504438A5 JP 2015504438 A5 JP2015504438 A5 JP 2015504438A5 JP 2014542858 A JP2014542858 A JP 2014542858A JP 2014542858 A JP2014542858 A JP 2014542858A JP 2015504438 A5 JP2015504438 A5 JP 2015504438A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- use according
- composition
- administered
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11190826.5A EP2596806A1 (en) | 2011-11-25 | 2011-11-25 | Method for prevention of colectomy |
| EP11190826.5 | 2011-11-25 | ||
| US201261595230P | 2012-02-06 | 2012-02-06 | |
| US61/595,230 | 2012-02-06 | ||
| PCT/EP2012/073501 WO2013076262A1 (en) | 2011-11-25 | 2012-11-23 | Method for prevention of colectomy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016218270A Division JP6318221B2 (ja) | 2011-11-25 | 2016-11-08 | 結腸切除の予防のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015504438A JP2015504438A (ja) | 2015-02-12 |
| JP2015504438A5 true JP2015504438A5 (cg-RX-API-DMAC7.html) | 2016-01-28 |
| JP6193248B2 JP6193248B2 (ja) | 2017-09-06 |
Family
ID=45094516
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014542858A Expired - Fee Related JP6193248B2 (ja) | 2011-11-25 | 2012-11-23 | 結腸切除の予防のための方法 |
| JP2016218270A Expired - Fee Related JP6318221B2 (ja) | 2011-11-25 | 2016-11-08 | 結腸切除の予防のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016218270A Expired - Fee Related JP6318221B2 (ja) | 2011-11-25 | 2016-11-08 | 結腸切除の予防のための方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US9492516B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP2596806A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6193248B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2892203C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1122089T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2782602T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2745677T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20191723T1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE046154T2 (cg-RX-API-DMAC7.html) |
| LT (1) | LT2782602T (cg-RX-API-DMAC7.html) |
| PL (1) | PL2782602T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2782602T (cg-RX-API-DMAC7.html) |
| RS (1) | RS59358B1 (cg-RX-API-DMAC7.html) |
| SI (1) | SI2782602T1 (cg-RX-API-DMAC7.html) |
| SM (1) | SMT201900527T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013076262A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2881808C (en) * | 2013-07-05 | 2021-08-17 | Sony Corporation | Transmission apparatus, transmission method, reception apparatus, and reception method |
| JP2019535839A (ja) | 2016-11-29 | 2019-12-12 | ピュアテック ヘルス エルエルシー | 治療剤の送達のためのエクソソーム |
| BR112019021520A2 (pt) | 2017-04-14 | 2020-08-04 | Tollnine, Inc. | oligonucleotídeo, composto, polinucleotídeo imunomodulador, composição, conjugado, método para modular um receptor, método de tratamento de um tumor, método de tratamento de câncer, método para tratar um tumor, método de prevenção de câncer, método para induzir uma resposta imune |
| GB201707501D0 (en) * | 2017-05-10 | 2017-06-21 | Index Pharmaceuticals Ab | New therapy 2 |
| GB201707503D0 (en) * | 2017-05-10 | 2017-06-21 | Index Pharmaceuticals Ab | New Therapy 3 |
| GB201807312D0 (en) * | 2018-05-03 | 2018-06-20 | Index Pharmaceuticals Ab | Formulation |
| GB201818579D0 (en) * | 2018-11-14 | 2018-12-26 | Index Pharmaceuticals Ab | New therapy |
| GB201912191D0 (en) * | 2019-08-24 | 2019-10-09 | Index Pharmaceuticals Ab | New therapy |
| EP4147688A1 (en) * | 2021-09-09 | 2023-03-15 | InDex Pharmaceuticals AB | Enema formulation |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5149797A (en) | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
| EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
| US5849719A (en) | 1993-08-26 | 1998-12-15 | The Regents Of The University Of California | Method for treating allergic lung disease |
| EP1167378B1 (en) | 1994-07-15 | 2011-05-11 | University of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| JP4359654B2 (ja) | 1996-01-30 | 2009-11-04 | ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア | 抗原特異的免疫応答を生起させる遺伝子発現ベクターおよびその使用方法 |
| ES2241042T3 (es) | 1996-10-11 | 2005-10-16 | The Regents Of The University Of California | Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora. |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US6426334B1 (en) | 1997-04-30 | 2002-07-30 | Hybridon, Inc. | Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal |
| US6339068B1 (en) | 1997-05-20 | 2002-01-15 | University Of Iowa Research Foundation | Vectors and methods for immunization or therapeutic protocols |
| US6809193B2 (en) * | 1997-08-13 | 2004-10-26 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide compositions and methods for the modulation of JNK proteins |
| AU2006205571B2 (en) | 2005-01-13 | 2012-03-22 | Progenika Biopharma, S.A. | Methods and products for in vitro genotyping |
| JPWO2006132204A1 (ja) | 2005-06-06 | 2009-01-08 | アンジェスＭｇ株式会社 | 転写因子デコイ |
| EP1904077B1 (en) | 2005-07-01 | 2009-08-12 | Index Pharmaceuticals AB | Modulating responsiveness to steroids |
| ES2450593T3 (es) | 2005-07-01 | 2014-03-25 | Index Pharmaceuticals Ab | Método inmunoestimulante |
| US8637479B2 (en) | 2008-11-04 | 2014-01-28 | Index Pharmaceuticals Ab | Compounds and methods for the treatment of inflammatory diseases of the CNS |
-
2011
- 2011-11-25 EP EP11190826.5A patent/EP2596806A1/en not_active Withdrawn
-
2012
- 2012-11-23 WO PCT/EP2012/073501 patent/WO2013076262A1/en not_active Ceased
- 2012-11-23 SI SI201231671T patent/SI2782602T1/sl unknown
- 2012-11-23 HU HUE12790904A patent/HUE046154T2/hu unknown
- 2012-11-23 EP EP19173912.7A patent/EP3556403A1/en not_active Withdrawn
- 2012-11-23 US US14/359,945 patent/US9492516B2/en not_active Expired - Fee Related
- 2012-11-23 LT LTEP12790904.2T patent/LT2782602T/lt unknown
- 2012-11-23 CA CA2892203A patent/CA2892203C/en active Active
- 2012-11-23 SM SM20190527T patent/SMT201900527T1/it unknown
- 2012-11-23 HR HRP20191723 patent/HRP20191723T1/hr unknown
- 2012-11-23 PT PT127909042T patent/PT2782602T/pt unknown
- 2012-11-23 ES ES12790904T patent/ES2745677T3/es active Active
- 2012-11-23 PL PL12790904T patent/PL2782602T3/pl unknown
- 2012-11-23 RS RSP20191190 patent/RS59358B1/sr unknown
- 2012-11-23 EP EP12790904.2A patent/EP2782602B1/en active Active
- 2012-11-23 DK DK12790904.2T patent/DK2782602T3/da active
- 2012-11-23 JP JP2014542858A patent/JP6193248B2/ja not_active Expired - Fee Related
-
2016
- 2016-09-14 US US15/264,709 patent/US9795627B2/en not_active Expired - Fee Related
- 2016-11-08 JP JP2016218270A patent/JP6318221B2/ja not_active Expired - Fee Related
-
2017
- 2017-09-21 US US15/711,228 patent/US20180015117A1/en not_active Abandoned
-
2019
- 2019-09-26 CY CY20191101013T patent/CY1122089T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015504438A5 (cg-RX-API-DMAC7.html) | ||
| HRP20191723T1 (hr) | Nukleotid dims0-150 za primjenu u liječenju kroničnog aktivnog ulceroznog kolitisa | |
| JP2016074736A5 (cg-RX-API-DMAC7.html) | ||
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| JP2015514418A5 (cg-RX-API-DMAC7.html) | ||
| IL317818A (en) | Oligonucleotides to reduce PD-L1 expression | |
| JP2014513954A5 (cg-RX-API-DMAC7.html) | ||
| JP2016195616A5 (cg-RX-API-DMAC7.html) | ||
| JP2018110601A5 (cg-RX-API-DMAC7.html) | ||
| JP2017505623A5 (cg-RX-API-DMAC7.html) | ||
| JP2014532704A5 (cg-RX-API-DMAC7.html) | ||
| MY161593A (en) | Oral formulations of cytidine analogs and methods of use thereof | |
| JP2013067645A5 (cg-RX-API-DMAC7.html) | ||
| JP2011225596A5 (cg-RX-API-DMAC7.html) | ||
| JP2013518107A5 (cg-RX-API-DMAC7.html) | ||
| JP2016508134A5 (cg-RX-API-DMAC7.html) | ||
| MX359548B (es) | Agentes de iarn modificados. | |
| JP2016517888A5 (cg-RX-API-DMAC7.html) | ||
| JP2015514778A5 (cg-RX-API-DMAC7.html) | ||
| JP2017521433A5 (cg-RX-API-DMAC7.html) | ||
| PH12014500965A1 (en) | Methods for treating cancers using oral formulations of cytidine analogs | |
| AR084319A1 (es) | INHIBIDORES DE microARN (miARN O miR) QUE COMPRENDEN NUCLEOTIDOS BLOQUEADOS | |
| FI3166615T3 (fi) | Kelatoituja fosforotioaattinukleiinihappopolymeerejä käytettäväksi yhdistelmänä HBV-polymeraasin inhibiittorin kanssa hepatiitti B- ja hepatiitti D -virusinfektioiden hoitamiseksi | |
| JP2015511821A5 (cg-RX-API-DMAC7.html) | ||
| BRPI0411098A (pt) | benzofuranocarboxamidas, com atividade pi3k, como agentes terapêuticos |